Long-term MRI changes in a patient with Kelch-like protein 11-associated paraneoplastic neurological syndrome.
Kelch-like protein 11
MRI
paraneoplastic syndrome
phage immunoprecipitation sequencing
susceptibility-weighted imaging
Journal
European journal of neurology
ISSN: 1468-1331
Titre abrégé: Eur J Neurol
Pays: England
ID NLM: 9506311
Informations de publication
Date de publication:
12 2021
12 2021
Historique:
revised:
13
09
2021
received:
03
08
2021
accepted:
17
09
2021
pubmed:
26
9
2021
medline:
2
4
2022
entrez:
25
9
2021
Statut:
ppublish
Résumé
The aim of this study was to identify the long-term radiological changes, autoantibody specificities, and clinical course in a patient with kelch-like protein 11 (KLHL11)-associated paraneoplastic neurological syndrome (PNS). Serial brain magnetic resonance images were retrospectively assessed. To test for KLHL11 autoantibodies, longitudinal cerebrospinal fluid (CSF) and serum samples were screened by Phage-display ImmunoPrecipitation and Sequencing (PhIP-Seq). Immunohistochemistry was also performed to assess for the presence of KLHL11 in the patient's seminoma tissue. A 42-year-old man presented with progressive ataxia and sensorineural hearing loss. Metastatic seminoma was detected 11 months after the onset of the neurological symptoms. Although immunotherapy was partially effective, his cerebellar ataxia gradually worsened over the next 8 years. Brain magnetic resonance imaging revealed progressive brainstem and cerebellar atrophy with a "hot-cross-bun sign", and low-signal intensity on susceptibility-weighted imaging (SWI) in the substantia nigra, red nucleus and dentate nuclei. PhIP-Seq enriched for KLHL11-derived peptides in all samples. Immunohistochemical staining of mouse brain with the patient CSF showed co-localization with a KLHL11 commercial antibody in the medulla and dentate nucleus. Immunohistochemical analysis of seminoma tissue showed anti-KLHL11 antibody-positive particles in cytoplasm. This study suggests that KLHL11-PNS should be included in the differential diagnosis for patients with brainstem and cerebellar atrophy and signal changes not only on T2-FLAIR but also on SWI, which might otherwise be interpreted as secondary to a neurodegenerative disease such as multiple system atrophy.
Sections du résumé
BACKGROUND AND PURPOSE
The aim of this study was to identify the long-term radiological changes, autoantibody specificities, and clinical course in a patient with kelch-like protein 11 (KLHL11)-associated paraneoplastic neurological syndrome (PNS).
METHODS
Serial brain magnetic resonance images were retrospectively assessed. To test for KLHL11 autoantibodies, longitudinal cerebrospinal fluid (CSF) and serum samples were screened by Phage-display ImmunoPrecipitation and Sequencing (PhIP-Seq). Immunohistochemistry was also performed to assess for the presence of KLHL11 in the patient's seminoma tissue.
RESULTS
A 42-year-old man presented with progressive ataxia and sensorineural hearing loss. Metastatic seminoma was detected 11 months after the onset of the neurological symptoms. Although immunotherapy was partially effective, his cerebellar ataxia gradually worsened over the next 8 years. Brain magnetic resonance imaging revealed progressive brainstem and cerebellar atrophy with a "hot-cross-bun sign", and low-signal intensity on susceptibility-weighted imaging (SWI) in the substantia nigra, red nucleus and dentate nuclei. PhIP-Seq enriched for KLHL11-derived peptides in all samples. Immunohistochemical staining of mouse brain with the patient CSF showed co-localization with a KLHL11 commercial antibody in the medulla and dentate nucleus. Immunohistochemical analysis of seminoma tissue showed anti-KLHL11 antibody-positive particles in cytoplasm.
CONCLUSIONS
This study suggests that KLHL11-PNS should be included in the differential diagnosis for patients with brainstem and cerebellar atrophy and signal changes not only on T2-FLAIR but also on SWI, which might otherwise be interpreted as secondary to a neurodegenerative disease such as multiple system atrophy.
Substances chimiques
Autoantibodies
0
Types de publication
Case Reports
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
4261-4266Subventions
Organisme : NINDS NIH HHS
ID : K99 NS117800
Pays : United States
Organisme : NINDS NIH HHS
ID : K08 NS096117
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH122471
Pays : United States
Informations de copyright
© 2021 European Academy of Neurology.
Références
Mandel-Brehm C, Dubey D, Kryzer TJ, et al. Kelch-like protein 11 antibodies in seminoma-associated paraneoplastic encephalitis. N Engl J Med. 2019;381:47-54.
Dubey D, Wilson MR, Clarkson B, et al. Expanded clinical phenotype, oncological associations, and immunopathologic insights of paraneoplastic Kelch-like protein-11 encephalitis. JAMA Neurol. 2020;77:1-10.
Vogrig A, Péricart S, Pinto AL, et al. Immunopathogenesis and proposed clinical score for identifying Kelch-like Protein-11 encephalitis. Brain Commun. 2021;3:fcab185.
Ishikawa H, Kawada N, Taniguchi A, et al. Paraneoplastic neurological syndrome due to burned-out testicular tumor showing hot cross-bun sign. Acta Neurol Scand. 2016;133:398-402.
Schmitz-Hübsch T, du Montcel ST, Baliko L, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology. 2006;66:1717-1720.
Dhanoa BS, Cogliati T, Satish AG, Bruford EA, Friedman JS. Update on the Kelch-like (KLHL) gene family. Hum Genomics. 2013;7:13.
Wong JK, Yu J, Patterson A, Carlson A, Shukla AW. Clinical and imaging features of newly recognized Kelch-like protein 11 paraneoplastic syndrome. Neurology. 2020;95:134-135.
Madhavan AA, Carr CM, Morris PP, et al. Imaging review of paraneoplastic neurologic syndromes. AJNR Am J Neuroradiol. 2020;41:2176-2187.
Madhavan A, Carr CM, Krecke KN, Wood CP, McKeon A, Dubey D. Association between paraneoplastic rhombencephalitis and hypertrophic olivary degeneration. J Neurol Neurosurg Pshyciatry. 2021;92:798-800.
Zuzuárregui JR, Shah A, Saint-Hilaire MH. Clinical reasoning: a 72-year-old man with nocturnal stridor. Neurology. 2015;85:e136-e139.
Gilman S, Wenning GK, Low PA, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology. 2008;71:670-676.
Yang J, Li X, yang R, et al. Susceptibility-weighted imaging manifestation in the brain of Wilson's disease patients. PLoS ONE. 2015;10(4):e0125100.
Wang N, Yang HG, Li CB, Fan GG, Luo XG. Using ‘swallow-tail’ sign and putaminal hypointensity as biomarkers to distinguish multiple system atrophy from idiopathic Parkinson's disease: a susceptibility-weighted imaging study. Eur Radiol. 2017;27:3174-3180.
Carré G, Dietemann JL, Gebus O, et al. Brain MRI of multiple system atrophy of cerebellar type: a prospective study with implications for diagnosis criteria. J Neurol. 2020;267:1269-1277.
Zhang HY, Tang H, Chen WX, et al. Mapping the functional connectivity of the substantia nigra, red nucleus and dentate nucleus: a network analysis hypothesis associated with the extrapyramidal system. Neurosci Lett. 2015;606:36-41.